ArticleInfectious diseases and therapy2025

Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulation.

Na Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.